Skip to content

Houmanfarma: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Houmanfarma

BE 0445.537.430
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€50,810
2024 · €80,799-€29,989
Equity
€330,819
2024 · €280,008+€50,810
Cash
€32,623
2024 · €50,775-€18,152
Balance sheet total
€700,955
2024 · €782,280-€81,324

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€68,662

    down €68,662 (-20.3%), from €337,851 to €269,189

    of which Land and buildings: -€44,714

  • Cash -€18,152

    down €18,152 (-35.8%), from €50,775 to €32,623

    mainly Other debts (-€77,594) and Trade debts (-€26,241)

  • Receivables within one year +€10,587

    up €10,587 (+9.5%), from €111,806 to €122,393

    of which Trade receivables: +€8,686

Equity and liabilities
  • Other debts -€77,594

    down €77,594 (-57.4%), from €135,252 to €57,658

  • Reserves +€50,810

    up €50,810 (+23.3%), from €218,035 to €268,845

    of which Distributable reserves: +€50,810

  • Trade debts -€26,241

    down €26,241 (-10.3%), from €255,227 to €228,986

  • Debts after one year -€22,153

    down €22,153 (-34.0%), from €65,076 to €42,923

  • Current portion of long-term debt -€9,838

    down €9,838 (-30.8%), from €31,991 to €22,153

Income statement
  • Gross operating margin -€30,528

    down €30,528 (-13.9%), from €219,282 to €188,754

  • Staff costs +€5,303

    up €5,303 (+15.3%), from €34,707 to €40,010

  • Financial charges -€4,555

    down €4,555 (-39.3%), from €11,580 to €7,026

  • Taxes -€3,806

    down €3,806 (-16.5%), from €23,114 to €19,307

  • Depreciation +€2,442

    up €2,442 (+3.6%), from €68,670 to €71,112

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €80,799
Gross operating margin -€30,528
Staff costs -€5,303
Depreciation -€2,442
Other operating charges -€77
Financial income -€0
Financial charges +€4,555
Taxes +€3,806
Result 2025 €50,810

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€12,952
Investment +€886
Financing -€31,991
Cash 2024 €50,775
Net result for the year +€50,810
Depreciation +€71,112
Receivables within one year -€10,587
Deferred charges and accrued income +€1,761
Trade debts -€26,241
Tax, wage and social debts +€3,691
Other debts -€77,594
Investment in fixed assets (net) +€886
Debts after one year -€22,153
Current portion of long-term debt -€9,838
Cash 2025 €32,623
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €782,280 €700,955 -€81,324 -10.4%
Fixed assets 21/28 €341,187 €269,189 -€71,998 -21.1%
Tangible fixed assets 22/27 €337,851 €269,189 -€68,662 -20.3%
Land and buildings 22 €221,356 €176,641 -€44,714 -20.2%
Plant, machinery and equipment 23 €115,308 €91,954 -€23,354 -20.3%
Furniture and vehicles 24 €1,187 €593 -€594 -50.0%
Financial fixed assets 28 €3,336 €0 -€3,336 -100.0%
Current assets 29/58 €441,093 €431,766 -€9,326 -2.1%
Stocks and contracts in progress 3 €270,384 €270,384 = 0.0%
Stocks 30/36 €270,384 €270,384 = 0.0%
Amounts receivable within one year 40/41 €111,806 €122,393 +€10,587 +9.5%
Trade receivables 40 €100,014 €108,700 +€8,686 +8.7%
Other amounts receivable 41 €11,792 €13,693 +€1,901 +16.1%
Cash at bank and in hand 54/58 €50,775 €32,623 -€18,152 -35.8%
Deferred charges and accrued income 490/1 €8,128 €6,367 -€1,761 -21.7%
Total equity and liabilities 10/49 €782,280 €700,955 -€81,324 -10.4%
Equity 10/15 €280,008 €330,819 +€50,810 +18.1%
Contributions 10/11 €61,973 €61,973 = 0.0%
Capital 10 €61,973 €61,973 = 0.0%
Issued capital 100 €61,973 €61,973 = 0.0%
Reserves 13 €218,035 €268,845 +€50,810 +23.3%
Non-distributable reserves 130/1 €6,197 €6,197 = 0.0%
Legal reserve 130 €6,197 €6,197 = 0.0%
Distributable reserves 133 €211,838 €262,648 +€50,810 +24.0%
Amounts payable 17/49 €502,271 €370,137 -€132,135 -26.3%
Amounts payable after more than one year 17 €65,076 €42,923 -€22,153 -34.0%
Financial debts 170/4 €65,076 €42,923 -€22,153 -34.0%
Amounts payable within one year 42/48 €437,195 €327,213 -€109,982 -25.2%
Current portion of amounts payable after more than one year 42 €31,991 €22,153 -€9,838 -30.8%
Trade debts 44 €255,227 €228,986 -€26,241 -10.3%
Suppliers 440/4 €255,227 €228,986 -€26,241 -10.3%
Taxes, remuneration and social security 45 €14,725 €18,417 +€3,691 +25.1%
Taxes 450/3 €8,114 €9,314 +€1,200 +14.8%
Remuneration and social security 454/9 €6,612 €9,103 +€2,491 +37.7%
Other amounts payable 47/48 €135,252 €57,658 -€77,594 -57.4%
Accrued charges and deferred income 492/3 €0 - =
Remuneration, social security and pensions 62 €34,707 €40,010 +€5,303 +15.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €68,670 €71,112 +€2,442 +3.6%
Other operating charges 640/8 €412 €489 +€77 +18.7%
Gross operating margin 9900 €219,282 €188,754 -€30,528 -13.9%
Operating profit (loss) 9901 €115,494 €77,143 -€38,350 -33.2%
Financial income 75/76B €0 €0 -€0 -100.0%
Recurring financial income 75 €0 €0 -€0 -100.0%
Financial charges 65/66B €11,580 €7,026 -€4,555 -39.3%
Recurring financial charges 65 €11,580 €7,026 -€4,555 -39.3%
Profit (loss) for the period before taxes 9903 €103,913 €70,118 -€33,795 -32.5%
Income taxes 67/77 €23,114 €19,307 -€3,806 -16.5%
Profit (loss) for the period 9904 €80,799 €50,810 -€29,989 -37.1%
Profit (loss) for the period to be appropriated 9905 €80,799 €50,810 -€29,989 -37.1%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.